-
RTA 408- MOXIe/ Reata Clinical trial
Have you participated in this trial? Although we cant discuss exactly how it made you feel, I would like to know what your experience was/is like.
For more information, click here
-
6 Replies
-
I did Phase 2, Part 1 in August-October of 2015. That was a placebo-controlled, dose escalation study so I may or may not have been on the drug, and if I was I have no idea what dose I was on. It was also only for 3 months.
I just screened for the extension study this past Monday. If everything looks good I’ll start in a few weeks! I’m excited because it’ll be a much different process than the first time. We are guaranteed the active medication at the most effective dose (derived from the results of the part 1 study we were in!). I know you know that but i wrote it out for others reading the forum 🙂 . There is no exercise testing in this study, so that’ll definitely be different!
I’m excited to start hearing some results from the Phase 2 Part 2 study. I know Reata started recruiting people in 2017 and enrolled the last person in November 2018. So that means some have already finished the year-long trial and the very last person will be done this November. This is just a guess but they might be able to give us some very preliminary results at CHOP this fall? Data analysis takes awhile but I’m optimistic that in early-mid 2020 we will start hearing some full results. Remember this was a pivotal Phase 2 trial, meaning the results are intended to provide evidence for FDA approval (no phase 3 trial). We shouldn’t get ahead of ourselves but if the results trickling in now are good, we may start hearing about the potential for FDA approval next year! That’s pretty cool to me 😀
-
@shandrajamie do keep us updated if the active medication is any good 🙂
I was planning on doing this trial but it was close to the end of enrollment and I was still a temp at my job so didn’t want to start missing days here and there.-
Hi Chris! While the trials are ongoing I can’t speak to my individual experience as that could disrupt the clinical trial process, however I can say that the published results from the Part 1 trial showed 3 months of treatment with the active medication led to neurological improvements (measured by FARS) equal to reversal of 1 year of FA progression!!! I am excited to hear the Part 2 results from the longer trial.
-
-
I am on moxie Phase 2 part 2. Year long trial so here till october.
-
Can you tell me where you read the published results from the part 1 trial? I have researched this a ton but want to make sure what I have read already is the most up to date info. Do you know if Dr. Lynch is involved with this study? From what I have researched this drug sounds promising. I want to be positive about this study but I am also trying to not get my hopes up:) I am new to all this, my daughter she is 9 was just diagnosed in October.
-
I am not sure, but maybe my brainy friends @shandrajamie or @jonathan can point us in the right direction?
-
Log in to reply.